The lawsuit, filed in Texas state court, alleges longtime Tylenol-maker Johnson & Johnson as well as Kenvue, which has sold the drug since being spun off in 2023, engaged in “deceptive trade practices ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback